Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Macarthys Laboratories Ltd t/a Martindale Pharma, Bampton Road, Harold Hill, Romford RM3 8UG
Morphine Sulfate 30mg in 1ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for Injection. A clear, colourless or almost colourless, particle free solution. |
Each 1 ml of solution contains 30 mg of Morphine Sulfate.
Excipients with known effect: Also, contains 2.23 mg of sodium per ml and sodium metabisulphite (E223).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Morphine |
Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation. |
| List of Excipients |
|---|
|
Sodium chloride, The pH may be adjusted with Sodium Hydroxide or Sulfuric Acid Solution. |
Clear, colourless 1ml Ph.Eur type1 glass ampoules containing sufficient solution to permit the removal of 1ml. 10 ampoules are packed into a cardboard carton.
Macarthys Laboratories Ltd t/a Martindale Pharma, Bampton Road, Harold Hill, Romford RM3 8UG
PL 01883/6178R
Date of first authorisation: 19th January, 1982
Renewal of authorisation: 19th August 2002
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
